AbelsonTaylor, Inc.

Share this article:
AbelsonTaylor, Inc.
AbelsonTaylor, Inc.
AbelsonTaylor, Inc.

335 E. Wacker Drive
Chicago, IL 60601
Phone: 312-894-5500 · Fax:312-894-5505
Email: info@abelsontaylor.com · Web: www.abelsontaylor.com
Founded: 1981 Officers: Dale Taylor, president; Jay Carter, SVP/director of client services;VP/account directors: Mike Perry, Greg Niemczyk, Cindy Stone, Allan Mills; John Reisdorf, VP/CFO; Beth Hall, VP, support services; VP/group creative directors: Stephen Neale, Angela Lustig, Rob Kienle, Josh Vizek, Scott Hansen.

Healthcare accounts: Abbott Labs: Zemplar international; Alexion Pharmaceuticals: Soliris; Amgen Inc.: Aranesp, Kepivance, Neulasta; Amgen Europe: Kepivance, Neulasta; Astellas: Vernakant; Astellas/GSK: VESIcare; Biogen Idec, Inc.: Avonex; Connetics Corporation: Evoclin, Kirlux, Olux/Lixig, Primolux; Genentech Inc./Biogen-Idec: Rituxan; Genentech Inc./Hoffman-La Roche Inc./OSI Pharmaceuticals Inc.: Tarceva; Gilead Science Inc.: Truvada; Lilly ICOS: Cialis; Eli Lilly and Company: Arxxant, Evista; Eli Lilly and Co./Amylin Pharmaceuticals: Byetta; MGI Pharma, Inc.: Aloxi, Dacogen, Gliadel Wafer; Sankyo/Forest: Benicar; Sankyo/Lilly: Prasugrel; Scios: Natrecor; Shire US Inc.: Pentasa, SPD503; Solvay Pharmaceuticals Inc.: Estratest, Prometrium; Takeda Pharmaceuticals North America, Inc.: Duetact, Rozerem; Takeda Pharmaceuticals America, Inc./Eli Lilly and Company: Actos, Actosplus Met; Ther-Rx Corporation: Clindesse, Encora, Gynazole-1, prenatal vitamins; Valeant Pharmaceuticals International: Tasmar; Zimmer: gender solutions - TM knee femoral implants.

Accounts gained (13): Abbott Labs: Zemplar international; Alexion Pharmaceuticals: Soliris; Astellas: Vernakant; Astellas/GSK: VESIcare; Connetics Corporation: Kirlux, Olux/Lixig, Primolux; Genentech Inc./Biogen-Idec: Rituxan; Lilly ICOS: Cialis; Sankyo/Forest: Benicar; Sankyo/Lilly: Prasugrel; Shire US Inc.: SPD503; Takeda Pharmaceuticals: Actosplus Met, Duetact; Ther-Rx Corporation: Encora, prenatal vitamins; Zimmer: gender solutions - TM knee femoral implants.

Accounts lost (7): Cell Therapeutics Inc.: Xyotax (resigned); La Jolla Pharmaceuticals: Riquent (promotion discontd.); MGI Pharma: Aggrastat (discontd.); Ross Laboratories: pediatric nutritional line (resigned); sanofi-aventis: Allegra, Allegra D (lost); Savient Pharmaceuticals: Oxandrin (lost); Solvay Pharmaceuticals: Estrogel (promotion discontd.).

New Hires: Keith Stenlund, VP/CFO.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Agency Gallery

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Agency Gallery

Agency Business briefs: June 2014

Agency Business briefs: June 2014

News on Publicis, Palio+Ignite, PulseCX, McCann HumanCare and GolinHarris

It's time to replace the FDA, says Newt Gingrich

It's time to replace the FDA, says Newt ...

Former Speaker of the House and presidential candidate Newt Gingrich has declared that it's time to replace FDA

Agency Business briefs: May 2014

Agency Business briefs: May 2014

Newson ID Media, Frontline Medical Communications and ContextMedia